Oncology & Cancer

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at the annual meeting of ...

Oncology & Cancer

Personalized blood test can detect persistent lung cancer

Patients who are at a higher risk of their lung cancer returning can be identified by a personalized blood test that is performed after treatment, according to researchers at the University of Cambridge.

page 7 from 26